Have you been eager to see how Global Payments Inc. (GPN - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Global Payments came out with adjusted earnings per share of $1.13 per share, beating the Zacks Consensus Estimate of $1.09 per share and grew 33% year over year.
Global Payments Inc. Price and EPS Surprise
Revenue Miss
Global payments posted revenues of $722.7 million which missed the Zacks Consensus Estimate of $918 million and declined 10.1% year over year.
Key Stats to Note
Total operating expense of $638.8 million decreased 21.6% year over year led by 44.6% drop in cost of service.
Adjusted operating margin improved 140 basis points to 30.4%.
Long term debt as of Mar 31, 2018 was $4.2 billion down from $4.6 billion at 2017 end.
Guidance Raised
For 2018 the company expects adjusted earnings to a range of $5.00-$5.20 from $4.95 to $5.15 per share guided earlier.
Adjusted net revenues are estimated between $3.9 billion and 3.975 billion from $3.88 billion to $3.97 billion expected previously.
Adjusted operating margin for 2018 is projected to expand 120 basis points.
What Zacks Rank Says
Global Payments carries a Zacks Rank #4 (Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Global Payments earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Have you been eager to see how Global Payments Inc. (GPN - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Global Payments came out with adjusted earnings per share of $1.13 per share, beating the Zacks Consensus Estimate of $1.09 per share and grew 33% year over year.
Global Payments Inc. Price and EPS Surprise
Revenue Miss
Global payments posted revenues of $722.7 million which missed the Zacks Consensus Estimate of $918 million and declined 10.1% year over year.
Key Stats to Note
Total operating expense of $638.8 million decreased 21.6% year over year led by 44.6% drop in cost of service.
Adjusted operating margin improved 140 basis points to 30.4%.
Long term debt as of Mar 31, 2018 was $4.2 billion down from $4.6 billion at 2017 end.
Guidance Raised
For 2018 the company expects adjusted earnings to a range of $5.00-$5.20 from $4.95 to $5.15 per share guided earlier.
Adjusted net revenues are estimated between $3.9 billion and 3.975 billion from $3.88 billion to $3.97 billion expected previously.
Adjusted operating margin for 2018 is projected to expand 120 basis points.
What Zacks Rank Says
Global Payments carries a Zacks Rank #4 (Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Global Payments earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on GPN - FREE